Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.
Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM.
Biol Blood Marrow Transplant. 2020 Jul;26(7):e161-e166. doi: 10.1016/j.bbmt.2020.04.027. Epub 2020 May 8.
HSCT: How Does It Work?
Galgano L, Hutt D.
2017 Nov 22. In: Kenyon M, Babic A, editors. The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT [Internet]. Cham (CH): Springer; 2018. Chapter 2.
AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001.
Hurraß J, Heinzow B, Walser-Reichenbach S, Aurbach U, Becker S, Bellmann R, Bergmann KC, Cornely OA, Engelhart S, Fischer G, Gabrio T, Herr CEW, Joest M, Karagiannidis C, Klimek L, Köberle M, Kolk A, Lichtnecker H, Lob-Corzilius T, Mülleneisen N, Nowak D, Rabe U, Raulf M, Steinmann J, Steiß JO, Stemler J, Umpfenbach U, Valtanen K, Werchan B, Willinger B, Wiesmüller GA.
Allergol Select. 2024 May 3;8:90-198. doi: 10.5414/ALX02444E. eCollection 2024.
Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
Stavi V, Khaire N, Lipton JH, Kumar R.
Curr Oncol. 2024 Feb 26;31(3):1246-1252. doi: 10.3390/curroncol31030093.
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, Liu QF, Wang JM, Wang X, Jiang M, Zhang X, Wu DP, Huang XJ.
J Hematol Oncol. 2017 Jan 21;10(1):25. doi: 10.1186/s13045-017-0398-y.
Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.
Ebens CL, DeFor TE, Tryon R, Wagner JE, MacMillan ML.
Biol Blood Marrow Transplant. 2018 Apr;24(4):765-771. doi: 10.1016/j.bbmt.2017.11.031. Epub 2017 Dec 2.
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH.
Haematologica. 2017 Jul;102(7):1291-1298. doi: 10.3324/haematol.2017.164459. Epub 2017 Mar 24.
Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report.
Niu H, Qi W, Wang Y, Xing L, Fu R, Shao Z, Wang H.
Medicine (Baltimore). 2020 Jun 5;99(23):e20669. doi: 10.1097/MD.0000000000020669.
Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
Gadalla SM, Wang T, Haagenson M, Spellman SR, Lee SJ, Williams KM, Wong JY, De Vivo I, Savage SA.
JAMA. 2015 Feb 10;313(6):594-602. doi: 10.1001/jama.2015.7.
Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
Zhang P, Feng K, Xue Y, Zhang CX, Wang Y, Li XL.
Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):155-161.
